Man who flipped car over onto roof is handed driving ban
A MAN who had been drinking when he flipped his car over onto its roof while driving through Marston Magna has been given a 16-month driving ban by the courts.
Ronnie Andrew Howes had been drinking before getting behind the wheel and being involved in a single vehicle accident on the A359.
After being taken to hospital for checks he provided a blood sample which showed he was over the limit, Somerset Magistrates were told.
Howes, 35, of Hood Road, Yeovil pleaded guilty to a charge of drink driving on November 2 last year.
Prosecutor Genna Morgan said on the day in question the police were alerted at 1.45pm of an accident involving a single car on the A359 at Marston Magna.
MORE COURT NEWS: Motorist - who swerved to avoid pothole and crashed - is banned for drink driving
'When they arrived they found a vehicle on its roof and could see the driver was under the influence of something, was slurring his words and smelt of alcohol,' she said.
Howes was checked over by paramedics and taken to hospital and a blood test revealed a reading of 129mlg of alcohol in 100ml of blood. The legal limit is 80mlg of alcohol.
Defending solicitor Greg Peters said his client blamed the incident on a 'moment of madness.'
'He says it will have a profound effect on his life both physically and mentally as he now has a serious wrist injury and limited mobility,' he said.
MORE COURT NEWS: Teenager on motorbike - with cocaine and cannabis in system - fled from police
'He is grateful that nobody else was hurt and just cannot explain why he drove that day.'
At the time Howes was homeless but had just secured a new job and would now be investing in a bike to be able to get to work.
Alongside the driving disqualification the magistrates fined him £461 with a £184 victim surcharge and £85 costs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
34 minutes ago
- Entrepreneur
4-Day Workweeks Lead to More Revenue, Less Burnout: Study
Working one day less per week improved revenue, retention, and employee health, according to a new study. Adopting a four-day workweek can improve employees' mental health and boost a business's bottom line, according to a new study. After studying over 245 businesses and nonprofits that have piloted a four-day workweek in their organizations over the past three years, Boston College economist Juliet B. Schor, also a lead researcher at 4Day Week Global, wrote in The Wall Street Journal that working one day less a week resulted in health benefits for employees. Nearly 70% of workers reported reduced burnout, over 40% experienced better mental health, and 37% saw better physical health. Related: 'Love It!': A Town in Connecticut Is Experimenting with a 4-Day Workweek — and It Seems to Be Working The pilot programs have reached 8,700 employees around the world, including the U.S., U.K., Brazil, and Ireland, and have lasted for at least six months at each company. On the employer side, the majority of organizations that piloted a four-day workweek noticed improved bottom-line metrics, including increased revenue and dwindling resignations. The results were so clear that over 90% of the more than 200 companies that started a six-month trial by June 2023 were still on a four-day workweek schedule a year later. Cloud computing provider Civo, which has 84 employees according to PitchBook, piloted the four-day week in 2020 and implemented it as company policy in January 2021. Civo CEO Mark Boost told The Register in April that the company has continued a four-day workweek for the past four years after positive feedback from staff and no decline in productivity. "Every employee is on a four-day week and most employees opted for Fridays off, which gives them a three-day weekend," Boost told The Register. Kickstarter also works on a four-day week, which started as a pilot program in 2021. Employee engagement is up 50% as a result. Kickstarter CEO Everette Taylor told Kevin O'Leary in July that employees are "very productive" within their four days of work per week. Related: This Country Just Implemented a 6-Day Workweek for Employees However, a four-day week can have disadvantages. According to the BBC, reducing the workweek by a day can lead to a more intense workload on the remaining four days, potentially causing more employee stress. In 2019, Microsoft Japan gave its 2,300-person workforce five Fridays off in a row in August without cutting their pay. The four-day workweeks led to 40% more productivity, with employees taking off 25% less time during the trial, according to the study. Despite the promising findings, Microsoft ended the program after trialing it without giving a reason for not implementing the four-day workweek as a permanent policy. Still, a recent survey shows that more than three in five U.S. employees want a four-day workweek, even if they have to work longer hours. The survey, released by LiveCareer in January, polled 1,130 Americans about their thoughts on a four-day workweek, working 10-hour days. Nearly 70% of employees supported a four-day week, predicting that it would make them more productive and lead to better work-life balance.
Medscape
2 hours ago
- Medscape
UK Pharmacies Struggle with Severe Creon Shortage
Nearly all UK pharmacies are experiencing severe 'challenges' supplying pancreatic enzyme replacement therapy (PERT), the National Pharmacy Association (NPA) warned. A sample survey by the association found that 96% of pharmacies were struggling to obtain Creon (pancrelipase, Mylan). A further 89% reported difficulties supplying PERT alternatives. Patients Resorting to Extreme Measures The ongoing shortage has forced patients to take desperate action, according to the NPA, which said some are rationing existing medication supplies or skipping meals entirely. One pharmacist described it as the 'worst stock shortage' they had ever encountered. Patients report eating only one meal daily, contacting multiple pharmacies for supplies, or travelling more than 30 miles to obtain the medication. Critical Medication for Serious Conditions Creon is used to treat pancreatic exocrine insufficiency from a variety of causes, including pancreatic cancer, cystic fibrosis, and pancreatitis. The medication, derived from porcine pancreatin, contains lipase, protease, and amylase. It dissolves rapidly in the stomach to release its enzyme load in the small intestine, where its lipolytic, amylolytic, and proteolytic activity enable absorption of the products of pancreatic digestion. PERT medications need to be taken to facilitate digestion every time a patient eats. In clinical trials, treatment with Creon markedly improved stool consistency, abdominal pain, and stool frequency, independent of the underlying disease. The consequences of inadequate dosing can be severe. Patients may become too unwell for surgery, struggle with chemotherapy tolerance, or experience debilitating symptoms that diminish quality of life. Symptoms may include diarrhoea, flatulence, bloating, abdominal pain, unexplained weight loss, and oily, foul-smelling stools (steatorrhoea). Safety Concerns Olivier Picard, NPA chair, warned the shortage has 'profound effects' on patients who depend on the medication to survive and lead normal lives. 'It simply cannot be right that in the 21st century patients are skipping meals in order to ration their medication,' he said. Last week, the government extended the current Serious Shortage Protocol (SSP) for Creon until 21 November 2025. The protocol allows pharmacists to use professional judgement to decide whether it's 'reasonable and appropriate' to substitute a patient's prescription for an alternative agent for one dispensing month. It allows pharmacies to supply a reduced quantity of Creon capsules that might be in stock, without having to send a patient back to their GP to get a new prescription. Two SSPs for Creon 10,000 and 25,000 capsules have been in place since May 2024. However, the survey found that 81% of pharmacies felt the current arrangements for managing the shortage were inadequate. In particular, pharmacists were still obliged to refer patients back to prescribers when seeking PERT alternatives. Alternative PERT formulations Nutrizym and Pancrex are also now in short supply as manufacturers struggle to meet demand. GPs and pharmacies can order unlicensed Creon or other PERT products from overseas, but other countries have experienced similar shortages. Calls for Regulatory Change The NPA and Pancreatic Cancer UK issued a joint statement urging government action. They called for a national plan to address shortages and support patients with alternative care. Picard said that although the situation was complex and not the fault of the government, medicine shortages were all too common. 'Highly trained pharmacists should also be permitted to use their professional judgment to supply alternative medicines — where it is safe and appropriate — in the event of the prescribed version being unavailable.' Alfie Bailey-Bearfield, head of influencing and health improvement at Pancreatic Cancer UK, said that the findings were 'deeply worrying'. It was 'totally unacceptable' that cancer patients were still taking desperate measures that put their health, wellbeing, and eligibility for treatment at risk, when the charity had been raising concerns with Department of Health and Social Care (DHSC) officials and PERT suppliers for more than a year. 'This crisis continues to put people's health on the line, and they cannot afford to wait any longer,' he said. A DHSC spokesperson said that the supply issues with Creon were European-wide and caused by limited availability of raw ingredients along with manufacturing capacity constraints. 'We are working closely with industry and the NHS to mitigate the impact on patients and resolve the issues as quickly as possible,' the spokesperson said.
Motor 1
2 hours ago
- Motor 1
McLaren Is Milking Its Le Mans History Again. But We're Here for It
Thirty years ago, McLaren won Le Mans on its debut, with JJ Lehto, Yannick Dalmas, and Masanori Sekiya piloting an F1 GTR to victory ahead of heavily favored protoypes. It helped seal the legend of the F1, and made McLaren the only constructor to win motorsport's triple crown, with victories at Le Mans, Monaco, and Indy. To commemorate, McLaren has created the 750S Le Mans, which has all kinds of neat details that reference the F1 GTR. McLaren will build 50 examples, each in one of two color options. The Le Mans Gray references the livery of the Uneo Clinic-sponsored car that won, while the McLaren Orange is painted in the company's traditional racing color. The car features a new High-Downforce Kit (HDK), which consists of a much larger splitter and a carbon-fiber wing out back. You also get roof scoop, and amazing five-spoke "LM" wheels that nod to the OZ Racing wheels used on the first F1 GTR race cars. The wheel center caps are red on one side of the car, and blue on the other, which is another race-car detail. Photo by: McLaren If you opt for the track brake upgrade kit, you get calipers in an anodized gold, like the Brembos on the original race car. Inside you can get black or gray trim with two different bucket seat options. The five-point harnesses are also blue, again, just like the GTR's, though we'll likely get regular old three-point belts here in the US. There are also plenty of options, most notably, a range of gloss carbon-fiber exterior components. This is actually McLaren's third Le Mans edition, with the company offering similar packages for the 650S and 720S. You could accuse McLaren of milking its history, but when the history is this good, why not? The F1 GTR is an icon among icons, and its victory in 1995 was the first for a debutant constructor in decades. It's also a feat that hasn't been repeated since. McLaren currently has GT3 cars racing at Le Mans, but it's making a comeback to the top class in 2027, with an LMDh prototype set to contest the World Endurance Championship. With any hope, that car could give McLaren another excuse to make a special edition. More on McLaren McLaren Will Make More Than Supercars The McLaren W1 Can Drive In Two Gears at Once Get the best news, reviews, columns, and more delivered straight to your inbox, daily. back Sign up For more information, read our Privacy Policy and Terms of Use . Share this Story Facebook X LinkedIn Flipboard Reddit WhatsApp E-Mail Got a tip for us? Email: tips@ Join the conversation ( )
